ArticleOncogene2013

A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo.

C Eberlein et al.PubMed ↗Publisher ↗

No numbers read from the abstract.